Morphine, at low doses, can promote pancreatic cancer progression via the activation of the JNK pathway secondary to p38 inhibition, whereas at high doses, it activates p38, leading to the suppression of the JNK pathway and, thus, of cancer growth [84]. Here, MAPK1 is linked to cancer.